United Therapeutics Surges After Tyvaso IPF Results United Therapeutics (UTHR) moved after Mar 30, 2026 Tyvaso data; IPF affects ~100,000 US patients and has a median survival of 3–5 years (Seeking Alpha; ALA).

United Therapeutics Surges After Tyvaso IPF Results: United Therapeutics (UTHR) moved after Mar 30, 2026 Tyvaso data; IPF affects ~100,000 US patients and has a median survival of 3–5 years (Seeking Alpha; ALA). 👈 Read full analysis #UnitedTherapeutics #Tyvaso #IPF #Healthcare #Pharmaceuticals